New immune therapy trial for tough thyroid cancers
Disease control
Terminated
This study tested whether a combination of two immunotherapy drugs (durvalumab and tremelimumab) could help control advanced thyroid cancers that had stopped responding to standard treatments. It enrolled 79 adults with different types of aggressive thyroid cancer that had spread…
Phase: PHASE2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC